Sign in

CIK 0001853816

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Dermata Therapeutics, Inc.

Sign in to watch
Ticker
DRMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 858-223-0882
Business address
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO, CA, 92130
Former names
Dermata Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-02 HALE DAVID F Director Grant or award · Stock Option (Right to Buy) +2,500 2,500
2025-01-23 HALE DAVID F Director Grant or award +78,741 80,957
2025-01-21 HALE DAVID F Director Grant or award · Warrant (Right to Buy) +78,741 78,741
2025-01-13 HALE DAVID F Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2024-01-04 HALE DAVID F Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2022-10-06 HALE DAVID F Director Grant or award +30,155 75,720
2022-07-07 HALE DAVID F Director Grant or award +26,441 45,565
2022-04-07 HALE DAVID F Director Grant or award +15,466 19,124
2022-01-03 HALE DAVID F Director Grant or award · Stock Option (right to buy) +5,000 5,000
2021-08-17 HALE DAVID F Director Conversion +44,777 299,411
2021-08-17 HALE DAVID F Director Conversion +12,195 311,606
2021-08-17 HALE DAVID F Director Conversion +20,000 331,606
2021-08-17 HALE DAVID F Director Conversion +174,216 505,822
2021-08-17 HALE DAVID F Director Conversion +27,103 532,925
2021-08-17 HALE DAVID F Director Purchase +35,714 35,714
2021-08-17 HALE DAVID F Director Conversion · Series 1d Preferred Stock −302,112 0
2021-08-17 HALE DAVID F Director Conversion · Series 1a Preferred Stock −250,000 0
2021-08-17 HALE DAVID F Director Conversion · Series 1b Preferred Stock −410,000 0
2021-08-17 HALE DAVID F Director Conversion · Series 1c Preferred Stock −3,571,428 0
2021-08-17 HALE DAVID F Director Conversion · Series 1 Preferred Stock −555,622 0

Page 1 of 2 · 23 trades